Report Overview
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The global Human Plasma-derived Hyperimmune Product market size was estimated at USD 1867 million in 2023 and is projected to reach USD 3208.23 million by 2032, exhibiting a CAGR of 6.20% during the forecast period.
North America Human Plasma-derived Hyperimmune Product market size was estimated at USD 539.57 million in 2023, at a CAGR of 5.31% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Human Plasma-derived Hyperimmune Product market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Plasma-derived Hyperimmune Product Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Plasma-derived Hyperimmune Product market in any manner.
Global Human Plasma-derived Hyperimmune Product Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market Segmentation (by Type)
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Market Segmentation (by Application)
Government Institution
Private Sector
Others
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Human Plasma-derived Hyperimmune Product Market
� Overview of the regional outlook of the Human Plasma-derived Hyperimmune Product Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Plasma-derived Hyperimmune Product Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Plasma-derived Hyperimmune Product, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Plasma-derived Hyperimmune Product
1.2 Key Market Segments
1.2.1 Human Plasma-derived Hyperimmune Product Segment by Type
1.2.2 Human Plasma-derived Hyperimmune Product Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Plasma-derived Hyperimmune Product Market Overview
2.1 Global Market Overview
2.1.1 Global Human Plasma-derived Hyperimmune Product Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Human Plasma-derived Hyperimmune Product Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Plasma-derived Hyperimmune Product Market Competitive Landscape
3.1 Global Human Plasma-derived Hyperimmune Product Sales by Manufacturers (2019-2025)
3.2 Global Human Plasma-derived Hyperimmune Product Revenue Market Share by Manufacturers (2019-2025)
3.3 Human Plasma-derived Hyperimmune Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Plasma-derived Hyperimmune Product Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Human Plasma-derived Hyperimmune Product Sales Sites, Area Served, Product Type
3.6 Human Plasma-derived Hyperimmune Product Market Competitive Situation and Trends
3.6.1 Human Plasma-derived Hyperimmune Product Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Plasma-derived Hyperimmune Product Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Plasma-derived Hyperimmune Product Industry Chain Analysis
4.1 Human Plasma-derived Hyperimmune Product Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Plasma-derived Hyperimmune Product Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Plasma-derived Hyperimmune Product Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Plasma-derived Hyperimmune Product Sales Market Share by Type (2019-2025)
6.3 Global Human Plasma-derived Hyperimmune Product Market Size Market Share by Type (2019-2025)
6.4 Global Human Plasma-derived Hyperimmune Product Price by Type (2019-2025)
7 Human Plasma-derived Hyperimmune Product Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Plasma-derived Hyperimmune Product Market Sales by Application (2019-2025)
7.3 Global Human Plasma-derived Hyperimmune Product Market Size (M USD) by Application (2019-2025)
7.4 Global Human Plasma-derived Hyperimmune Product Sales Growth Rate by Application (2019-2025)
8 Human Plasma-derived Hyperimmune Product Market Consumption by Region
8.1 Global Human Plasma-derived Hyperimmune Product Sales by Region
8.1.1 Global Human Plasma-derived Hyperimmune Product Sales by Region
8.1.2 Global Human Plasma-derived Hyperimmune Product Sales Market Share by Region
8.2 North America
8.2.1 North America Human Plasma-derived Hyperimmune Product Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Plasma-derived Hyperimmune Product Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Plasma-derived Hyperimmune Product Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Plasma-derived Hyperimmune Product Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Plasma-derived Hyperimmune Product Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Human Plasma-derived Hyperimmune Product Market Production by Region
9.1 Global Production of Human Plasma-derived Hyperimmune Product by Region (2019-2025)
9.2 Global Human Plasma-derived Hyperimmune Product Revenue Market Share by Region (2019-2025)
9.3 Global Human Plasma-derived Hyperimmune Product Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Human Plasma-derived Hyperimmune Product Production
9.4.1 North America Human Plasma-derived Hyperimmune Product Production Growth Rate (2019-2025)
9.4.2 North America Human Plasma-derived Hyperimmune Product Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Human Plasma-derived Hyperimmune Product Production
9.5.1 Europe Human Plasma-derived Hyperimmune Product Production Growth Rate (2019-2025)
9.5.2 Europe Human Plasma-derived Hyperimmune Product Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Human Plasma-derived Hyperimmune Product Production (2019-2025)
9.6.1 Japan Human Plasma-derived Hyperimmune Product Production Growth Rate (2019-2025)
9.6.2 Japan Human Plasma-derived Hyperimmune Product Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Human Plasma-derived Hyperimmune Product Production (2019-2025)
9.7.1 China Human Plasma-derived Hyperimmune Product Production Growth Rate (2019-2025)
9.7.2 China Human Plasma-derived Hyperimmune Product Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 CSL Behring
10.1.1 CSL Behring Human Plasma-derived Hyperimmune Product Basic Information
10.1.2 CSL Behring Human Plasma-derived Hyperimmune Product Product Overview
10.1.3 CSL Behring Human Plasma-derived Hyperimmune Product Product Market Performance
10.1.4 CSL Behring Business Overview
10.1.5 CSL Behring Human Plasma-derived Hyperimmune Product SWOT Analysis
10.1.6 CSL Behring Recent Developments
10.2 Grifols
10.2.1 Grifols Human Plasma-derived Hyperimmune Product Basic Information
10.2.2 Grifols Human Plasma-derived Hyperimmune Product Product Overview
10.2.3 Grifols Human Plasma-derived Hyperimmune Product Product Market Performance
10.2.4 Grifols Business Overview
10.2.5 Grifols Human Plasma-derived Hyperimmune Product SWOT Analysis
10.2.6 Grifols Recent Developments
10.3 Biotest
10.3.1 Biotest Human Plasma-derived Hyperimmune Product Basic Information
10.3.2 Biotest Human Plasma-derived Hyperimmune Product Product Overview
10.3.3 Biotest Human Plasma-derived Hyperimmune Product Product Market Performance
10.3.4 Biotest Human Plasma-derived Hyperimmune Product SWOT Analysis
10.3.5 Biotest Business Overview
10.3.6 Biotest Recent Developments
10.4 Kedrion
10.4.1 Kedrion Human Plasma-derived Hyperimmune Product Basic Information
10.4.2 Kedrion Human Plasma-derived Hyperimmune Product Product Overview
10.4.3 Kedrion Human Plasma-derived Hyperimmune Product Product Market Performance
10.4.4 Kedrion Business Overview
10.4.5 Kedrion Recent Developments
10.5 CBPO
10.5.1 CBPO Human Plasma-derived Hyperimmune Product Basic Information
10.5.2 CBPO Human Plasma-derived Hyperimmune Product Product Overview
10.5.3 CBPO Human Plasma-derived Hyperimmune Product Product Market Performance
10.5.4 CBPO Business Overview
10.5.5 CBPO Recent Developments
10.6 Emergent (Cangene)
10.6.1 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Basic Information
10.6.2 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Product Overview
10.6.3 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Product Market Performance
10.6.4 Emergent (Cangene) Business Overview
10.6.5 Emergent (Cangene) Recent Developments
10.7 Kamada
10.7.1 Kamada Human Plasma-derived Hyperimmune Product Basic Information
10.7.2 Kamada Human Plasma-derived Hyperimmune Product Product Overview
10.7.3 Kamada Human Plasma-derived Hyperimmune Product Product Market Performance
10.7.4 Kamada Business Overview
10.7.5 Kamada Recent Developments
10.8 CNBG
10.8.1 CNBG Human Plasma-derived Hyperimmune Product Basic Information
10.8.2 CNBG Human Plasma-derived Hyperimmune Product Product Overview
10.8.3 CNBG Human Plasma-derived Hyperimmune Product Product Market Performance
10.8.4 CNBG Business Overview
10.8.5 CNBG Recent Developments
10.9 Hualan Bio
10.9.1 Hualan Bio Human Plasma-derived Hyperimmune Product Basic Information
10.9.2 Hualan Bio Human Plasma-derived Hyperimmune Product Product Overview
10.9.3 Hualan Bio Human Plasma-derived Hyperimmune Product Product Market Performance
10.9.4 Hualan Bio Business Overview
10.9.5 Hualan Bio Recent Developments
10.10 Shanghai RAAS
10.10.1 Shanghai RAAS Human Plasma-derived Hyperimmune Product Basic Information
10.10.2 Shanghai RAAS Human Plasma-derived Hyperimmune Product Product Overview
10.10.3 Shanghai RAAS Human Plasma-derived Hyperimmune Product Product Market Performance
10.10.4 Shanghai RAAS Business Overview
10.10.5 Shanghai RAAS Recent Developments
10.11 Sichuan Yuanda Shuyang
10.11.1 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Basic Information
10.11.2 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Product Overview
10.11.3 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Product Market Performance
10.11.4 Sichuan Yuanda Shuyang Business Overview
10.11.5 Sichuan Yuanda Shuyang Recent Developments
10.12 ADMA Biologics
10.12.1 ADMA Biologics Human Plasma-derived Hyperimmune Product Basic Information
10.12.2 ADMA Biologics Human Plasma-derived Hyperimmune Product Product Overview
10.12.3 ADMA Biologics Human Plasma-derived Hyperimmune Product Product Market Performance
10.12.4 ADMA Biologics Business Overview
10.12.5 ADMA Biologics Recent Developments
11 Human Plasma-derived Hyperimmune Product Market Forecast by Region
11.1 Global Human Plasma-derived Hyperimmune Product Market Size Forecast
11.2 Global Human Plasma-derived Hyperimmune Product Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Plasma-derived Hyperimmune Product Market Size Forecast by Country
11.2.3 Asia Pacific Human Plasma-derived Hyperimmune Product Market Size Forecast by Region
11.2.4 South America Human Plasma-derived Hyperimmune Product Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Human Plasma-derived Hyperimmune Product by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Human Plasma-derived Hyperimmune Product Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Human Plasma-derived Hyperimmune Product by Type (2025-2032)
12.1.2 Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Human Plasma-derived Hyperimmune Product by Type (2025-2032)
12.2 Global Human Plasma-derived Hyperimmune Product Market Forecast by Application (2025-2032)
12.2.1 Global Human Plasma-derived Hyperimmune Product Sales (K MT) Forecast by Application
12.2.2 Global Human Plasma-derived Hyperimmune Product Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Plasma-derived Hyperimmune Product Market Size Comparison by Region (M USD)
Table 5. Global Human Plasma-derived Hyperimmune Product Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Human Plasma-derived Hyperimmune Product Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Human Plasma-derived Hyperimmune Product Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Plasma-derived Hyperimmune Product as of 2022)
Table 10. Global Market Human Plasma-derived Hyperimmune Product Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Human Plasma-derived Hyperimmune Product Sales Sites and Area Served
Table 12. Manufacturers Human Plasma-derived Hyperimmune Product Product Type
Table 13. Global Human Plasma-derived Hyperimmune Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Plasma-derived Hyperimmune Product
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Plasma-derived Hyperimmune Product Market Challenges
Table 22. Global Human Plasma-derived Hyperimmune Product Sales by Type (K MT)
Table 23. Global Human Plasma-derived Hyperimmune Product Market Size by Type (M USD)
Table 24. Global Human Plasma-derived Hyperimmune Product Sales (K MT) by Type (2019-2025)
Table 25. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Type (2019-2025)
Table 26. Global Human Plasma-derived Hyperimmune Product Market Size (M USD) by Type (2019-2025)
Table 27. Global Human Plasma-derived Hyperimmune Product Market Size Share by Type (2019-2025)
Table 28. Global Human Plasma-derived Hyperimmune Product Price (USD/MT) by Type (2019-2025)
Table 29. Global Human Plasma-derived Hyperimmune Product Sales (K MT) by Application
Table 30. Global Human Plasma-derived Hyperimmune Product Market Size by Application
Table 31. Global Human Plasma-derived Hyperimmune Product Sales by Application (2019-2025) & (K MT)
Table 32. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Application (2019-2025)
Table 33. Global Human Plasma-derived Hyperimmune Product Sales by Application (2019-2025) & (M USD)
Table 34. Global Human Plasma-derived Hyperimmune Product Market Share by Application (2019-2025)
Table 35. Global Human Plasma-derived Hyperimmune Product Sales Growth Rate by Application (2019-2025)
Table 36. Global Human Plasma-derived Hyperimmune Product Sales by Region (2019-2025) & (K MT)
Table 37. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Region (2019-2025)
Table 38. North America Human Plasma-derived Hyperimmune Product Sales by Country (2019-2025) & (K MT)
Table 39. Europe Human Plasma-derived Hyperimmune Product Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Human Plasma-derived Hyperimmune Product Sales by Region (2019-2025) & (K MT)
Table 41. South America Human Plasma-derived Hyperimmune Product Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Human Plasma-derived Hyperimmune Product Sales by Region (2019-2025) & (K MT)
Table 43. Global Human Plasma-derived Hyperimmune Product Production (K MT) by Region (2019-2025)
Table 44. Global Human Plasma-derived Hyperimmune Product Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Human Plasma-derived Hyperimmune Product Revenue Market Share by Region (2019-2025)
Table 46. Global Human Plasma-derived Hyperimmune Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Human Plasma-derived Hyperimmune Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Human Plasma-derived Hyperimmune Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Human Plasma-derived Hyperimmune Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Human Plasma-derived Hyperimmune Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. CSL Behring Human Plasma-derived Hyperimmune Product Basic Information
Table 52. CSL Behring Human Plasma-derived Hyperimmune Product Product Overview
Table 53. CSL Behring Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. CSL Behring Business Overview
Table 55. CSL Behring Human Plasma-derived Hyperimmune Product SWOT Analysis
Table 56. CSL Behring Recent Developments
Table 57. Grifols Human Plasma-derived Hyperimmune Product Basic Information
Table 58. Grifols Human Plasma-derived Hyperimmune Product Product Overview
Table 59. Grifols Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Grifols Business Overview
Table 61. Grifols Human Plasma-derived Hyperimmune Product SWOT Analysis
Table 62. Grifols Recent Developments
Table 63. Biotest Human Plasma-derived Hyperimmune Product Basic Information
Table 64. Biotest Human Plasma-derived Hyperimmune Product Product Overview
Table 65. Biotest Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Biotest Human Plasma-derived Hyperimmune Product SWOT Analysis
Table 67. Biotest Business Overview
Table 68. Biotest Recent Developments
Table 69. Kedrion Human Plasma-derived Hyperimmune Product Basic Information
Table 70. Kedrion Human Plasma-derived Hyperimmune Product Product Overview
Table 71. Kedrion Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Kedrion Business Overview
Table 73. Kedrion Recent Developments
Table 74. CBPO Human Plasma-derived Hyperimmune Product Basic Information
Table 75. CBPO Human Plasma-derived Hyperimmune Product Product Overview
Table 76. CBPO Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. CBPO Business Overview
Table 78. CBPO Recent Developments
Table 79. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Basic Information
Table 80. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Product Overview
Table 81. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Emergent (Cangene) Business Overview
Table 83. Emergent (Cangene) Recent Developments
Table 84. Kamada Human Plasma-derived Hyperimmune Product Basic Information
Table 85. Kamada Human Plasma-derived Hyperimmune Product Product Overview
Table 86. Kamada Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Kamada Business Overview
Table 88. Kamada Recent Developments
Table 89. CNBG Human Plasma-derived Hyperimmune Product Basic Information
Table 90. CNBG Human Plasma-derived Hyperimmune Product Product Overview
Table 91. CNBG Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. CNBG Business Overview
Table 93. CNBG Recent Developments
Table 94. Hualan Bio Human Plasma-derived Hyperimmune Product Basic Information
Table 95. Hualan Bio Human Plasma-derived Hyperimmune Product Product Overview
Table 96. Hualan Bio Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Hualan Bio Business Overview
Table 98. Hualan Bio Recent Developments
Table 99. Shanghai RAAS Human Plasma-derived Hyperimmune Product Basic Information
Table 100. Shanghai RAAS Human Plasma-derived Hyperimmune Product Product Overview
Table 101. Shanghai RAAS Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Shanghai RAAS Business Overview
Table 103. Shanghai RAAS Recent Developments
Table 104. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Basic Information
Table 105. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Product Overview
Table 106. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Sichuan Yuanda Shuyang Business Overview
Table 108. Sichuan Yuanda Shuyang Recent Developments
Table 109. ADMA Biologics Human Plasma-derived Hyperimmune Product Basic Information
Table 110. ADMA Biologics Human Plasma-derived Hyperimmune Product Product Overview
Table 111. ADMA Biologics Human Plasma-derived Hyperimmune Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. ADMA Biologics Business Overview
Table 113. ADMA Biologics Recent Developments
Table 114. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Region (2025-2032) & (K MT)
Table 115. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Human Plasma-derived Hyperimmune Product Sales Forecast by Country (2025-2032) & (K MT)
Table 117. North America Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Human Plasma-derived Hyperimmune Product Sales Forecast by Country (2025-2032) & (K MT)
Table 119. Europe Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Human Plasma-derived Hyperimmune Product Sales Forecast by Region (2025-2032) & (K MT)
Table 121. Asia Pacific Human Plasma-derived Hyperimmune Product Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Human Plasma-derived Hyperimmune Product Sales Forecast by Country (2025-2032) & (K MT)
Table 123. South America Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Human Plasma-derived Hyperimmune Product Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Type (2025-2032) & (K MT)
Table 127. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Human Plasma-derived Hyperimmune Product Price Forecast by Type (2025-2032) & (USD/MT)
Table 129. Global Human Plasma-derived Hyperimmune Product Sales (K MT) Forecast by Application (2025-2032)
Table 130. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Human Plasma-derived Hyperimmune Product
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Plasma-derived Hyperimmune Product Market Size (M USD), 2019-2032
Figure 5. Global Human Plasma-derived Hyperimmune Product Market Size (M USD) (2019-2032)
Figure 6. Global Human Plasma-derived Hyperimmune Product Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Plasma-derived Hyperimmune Product Market Size by Country (M USD)
Figure 11. Human Plasma-derived Hyperimmune Product Sales Share by Manufacturers in 2023
Figure 12. Global Human Plasma-derived Hyperimmune Product Revenue Share by Manufacturers in 2023
Figure 13. Human Plasma-derived Hyperimmune Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Plasma-derived Hyperimmune Product Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Plasma-derived Hyperimmune Product Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Plasma-derived Hyperimmune Product Market Share by Type
Figure 18. Sales Market Share of Human Plasma-derived Hyperimmune Product by Type (2019-2025)
Figure 19. Sales Market Share of Human Plasma-derived Hyperimmune Product by Type in 2023
Figure 20. Market Size Share of Human Plasma-derived Hyperimmune Product by Type (2019-2025)
Figure 21. Market Size Market Share of Human Plasma-derived Hyperimmune Product by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Plasma-derived Hyperimmune Product Market Share by Application
Figure 24. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Application (2019-2025)
Figure 25. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Application in 2023
Figure 26. Global Human Plasma-derived Hyperimmune Product Market Share by Application (2019-2025)
Figure 27. Global Human Plasma-derived Hyperimmune Product Market Share by Application in 2023
Figure 28. Global Human Plasma-derived Hyperimmune Product Sales Growth Rate by Application (2019-2025)
Figure 29. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Region (2019-2025)
Figure 30. North America Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Human Plasma-derived Hyperimmune Product Sales Market Share by Country in 2023
Figure 32. U.S. Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Human Plasma-derived Hyperimmune Product Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Human Plasma-derived Hyperimmune Product Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Human Plasma-derived Hyperimmune Product Sales Market Share by Country in 2023
Figure 37. Germany Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Human Plasma-derived Hyperimmune Product Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Human Plasma-derived Hyperimmune Product Sales Market Share by Region in 2023
Figure 44. China Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Human Plasma-derived Hyperimmune Product Sales and Growth Rate (K MT)
Figure 50. South America Human Plasma-derived Hyperimmune Product Sales Market Share by Country in 2023
Figure 51. Brazil Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Human Plasma-derived Hyperimmune Product Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Human Plasma-derived Hyperimmune Product Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Human Plasma-derived Hyperimmune Product Production Market Share by Region (2019-2025)
Figure 62. North America Human Plasma-derived Hyperimmune Product Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Human Plasma-derived Hyperimmune Product Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Human Plasma-derived Hyperimmune Product Production (K MT) Growth Rate (2019-2025)
Figure 65. China Human Plasma-derived Hyperimmune Product Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Human Plasma-derived Hyperimmune Product Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Human Plasma-derived Hyperimmune Product Market Share Forecast by Type (2025-2032)
Figure 70. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Application (2025-2032)
Figure 71. Global Human Plasma-derived Hyperimmune Product Market Share Forecast by Application (2025-2032)
